Nektar Therapeutics
NKTR· Nasdaq
Released Aug 5, 2015, after the close
10-Q filed Aug 6, 2015, 37 days after period end · 0001193125-15-279400
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2015 | Q2 2014 | Q2 2013 | Q2 2012 |
|---|---|---|---|---|
| Revenue | $22.66M | $28.51M | $33.86M | $23.68M |
| Net Income | -$52.66M | -$32.64M | -$42.75M | -$34.29M |
| EPS Diluted | -$0.40 |
Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR
| -$0.26 |
| -$0.37 |
| -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.